PMID- 19722282 OWN - NLM STAT- MEDLINE DCOM- 20100708 LR - 20220227 IS - 1552-4965 (Electronic) IS - 1549-3296 (Print) IS - 1549-3296 (Linking) VI - 93 IP - 3 DP - 2010 Jun 1 TI - The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. PG - 994-1003 LID - 10.1002/jbm.a.32589 [doi] AB - Adipose-derived stem cells (ASCs) are multipotent progenitors that can be chondrogenically induced by growth factors such as bone morphogenetic protein 6 (BMP-6). We hypothesized that nonviral transfection of a BMP-6 construct (pcDNA3-BMP6) would induce chondrogenic differentiation of ASCs encapsulated in alginate beads and that differentiation would be enhanced by the presence of the synthetic glucocorticoid dexamethasone (DEX) or the combination of epidermal growth factor (EGF), fibroblast growth factor-2 (FGF-2), and transforming growth factor beta-1 (TGF-beta1), collectively termed expansion factors (EFs). Chondrogenesis was assessed using quantitative real-time polymerase chain reaction for types I, II, and X collagen, aggrecan, and BMP6. Immunohistochemistry was performed with antibodies for types I, II, and X collagen and chondroitin-4-sulfate. BMP6 overexpression alone induced a moderate chondrogenic response. The inclusion of EFs promoted robust type II collagen expression but also increased type I and X collagen deposition, consistent with a hypertrophic chondrocyte phenotype. Early gene expression data indicated that DEX was synergistic with BMP-6 for chondrogenesis, but immunohistochemistry at 28 days showed that DEX reduced glycosaminoglycan accumulation. These results suggest that chondrogenic differentiation of ASCs depends on complex interactions among various growth factors and media supplements, as well as the concentration and duration of growth factor exposure. FAU - Diekman, Brian O AU - Diekman BO AD - Orthopaedic Research Laboratories, Department of Surgery, Division of Orthopaedic Surgery, 375 MSRB, Box 3093, Duke University Medical Center, Durham, North Carolina 27710, USA. FAU - Estes, Bradley T AU - Estes BT FAU - Guilak, Farshid AU - Guilak F LA - eng GR - T32 GM008555/GM/NIGMS NIH HHS/United States GR - GM08555/GM/NIGMS NIH HHS/United States GR - AG15768/AG/NIA NIH HHS/United States GR - R01 AR048852/AR/NIAMS NIH HHS/United States GR - R01 AR048182/AR/NIAMS NIH HHS/United States GR - AR48852/AR/NIAMS NIH HHS/United States GR - RR024128/RR/NCRR NIH HHS/United States GR - AR50245/AR/NIAMS NIH HHS/United States GR - P01 AR050245/AR/NIAMS NIH HHS/United States GR - R01 AG015768/AG/NIA NIH HHS/United States GR - UL1 RR024128/RR/NCRR NIH HHS/United States GR - AR48182/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Biomed Mater Res A JT - Journal of biomedical materials research. Part A JID - 101234237 RN - 0 (Bone Morphogenetic Protein 6) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 7S5I7G3JQL (Dexamethasone) RN - 9007-28-7 (Chondroitin Sulfates) RN - 9007-34-5 (Collagen) SB - IM MH - Adipose Tissue/*cytology MH - Adult MH - Bone Morphogenetic Protein 6/genetics/*metabolism MH - Cells, Cultured MH - Chondrogenesis/*drug effects/genetics MH - Chondroitin Sulfates/metabolism MH - Collagen/genetics/metabolism MH - Dexamethasone/*pharmacology MH - Female MH - Gene Expression Regulation/drug effects MH - Humans MH - Immunohistochemistry MH - Intercellular Signaling Peptides and Proteins/*pharmacology MH - Polymerase Chain Reaction MH - Stem Cells/*cytology/drug effects/metabolism PMC - PMC3616877 MID - NIHMS453928 EDAT- 2009/09/02 06:00 MHDA- 2010/07/09 06:00 PMCR- 2013/04/04 CRDT- 2009/09/02 09:00 PHST- 2009/09/02 09:00 [entrez] PHST- 2009/09/02 06:00 [pubmed] PHST- 2010/07/09 06:00 [medline] PHST- 2013/04/04 00:00 [pmc-release] AID - 10.1002/jbm.a.32589 [doi] PST - ppublish SO - J Biomed Mater Res A. 2010 Jun 1;93(3):994-1003. doi: 10.1002/jbm.a.32589.